These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
193 related articles for article (PubMed ID: 17582472)
21. Factor XIII Val34Leu variant is protective against venous thromboembolism: a HuGE review and meta-analysis. Wells PS; Anderson JL; Scarvelis DK; Doucette SP; Gagnon F Am J Epidemiol; 2006 Jul; 164(2):101-9. PubMed ID: 16740590 [TBL] [Abstract][Full Text] [Related]
22. The genetics of venous thromboembolism. A meta-analysis involving approximately 120,000 cases and 180,000 controls. Gohil R; Peck G; Sharma P Thromb Haemost; 2009 Aug; 102(2):360-70. PubMed ID: 19652888 [TBL] [Abstract][Full Text] [Related]
23. Fibrinogen polymorphisms TaqI, HaeIII and BclI are not associated with a higher risk of deep vein thrombosis. Bozic M; Teran N; Peterlin B; Stegnar M Pathophysiol Haemost Thromb; 2003; 33(3):164-9. PubMed ID: 15170397 [TBL] [Abstract][Full Text] [Related]
24. Factor XIII val34leu and the risk of myocardial infarction. Franco RF; Pazin-Filho A; Tavella MH; Simões MV; Marin-Neto JA; Zago MA Haematologica; 2000 Jan; 85(1):67-71. PubMed ID: 10629595 [TBL] [Abstract][Full Text] [Related]
25. Mutations in clotting factors and inflammatory bowel disease. Bernstein CN; Sargent M; Vos HL; Rosendaal FR Am J Gastroenterol; 2007 Feb; 102(2):338-43. PubMed ID: 17156138 [TBL] [Abstract][Full Text] [Related]
26. A common mutation in the gene for coagulation factor XIII-A (VAL34Leu): a risk factor for primary intracerebral hemorrhage is protective against atherothrombotic diseases. Gemmati D; Serino ML; Ongaro A; Tognazzo S; Moratelli S; Resca R; Moretti M; Scapoli GL Am J Hematol; 2001 Jul; 67(3):183-8. PubMed ID: 11391716 [TBL] [Abstract][Full Text] [Related]
27. ABO blood group but not haemostasis genetic polymorphisms significantly influence thrombotic risk: a study of 180 homozygotes for the Factor V Leiden mutation. Procare-GEHT Group Br J Haematol; 2006 Dec; 135(5):697-702. PubMed ID: 17107352 [TBL] [Abstract][Full Text] [Related]
28. Analysis of prothrombotic mutations and polymorphisms in children who developed thrombosis in the perioperative period of congenital cardiac surgery. Ozbek N; Ataç FB; Yildirim SV; Verdi H; Yazici C; Yilmaz BT; Tokel NK Cardiol Young; 2005 Feb; 15(1):19-25. PubMed ID: 15831156 [TBL] [Abstract][Full Text] [Related]
30. Impact of genetic polymorphisms in thrombin activatable fibrinolysis inhibitor (TAFI) on venous thrombosis disease: A meta-analysis. Qian K; Xu J; Wan H; Fu F; Lu J; Lin Z; Liu Z; Liu H Gene; 2015 Sep; 569(2):173-81. PubMed ID: 26071134 [TBL] [Abstract][Full Text] [Related]
31. Venous thrombosis in relation to fibrinogen and factor VII genes among African-Americans. Austin H; Hooper WC; Lally C; Dilley A; Ellingsen D; Wideman C; Wenger NK; Rawlins P; Silva V; Evatt B J Clin Epidemiol; 2000 Oct; 53(10):997-1001. PubMed ID: 11027931 [TBL] [Abstract][Full Text] [Related]
32. Role of factor XIII Val34Leu polymorphism in retinal artery occlusion. Weger M; Renner W; Stanger O; Schmut O; Deutschmann H; Wascher TC; Haas A Stroke; 2001 Dec; 32(12):2759-61. PubMed ID: 11739969 [TBL] [Abstract][Full Text] [Related]
33. The factor XIII Val34Leu polymorphism: is it protective against idiopathic venous thromboembolism? Wells PS; Anderson JL; Rodger MA; Carson N; Grimwood RL; Doucette SP Blood Coagul Fibrinolysis; 2006 Oct; 17(7):533-8. PubMed ID: 16988547 [TBL] [Abstract][Full Text] [Related]
34. Gene polymorphisms implicated in influencing susceptibility to venous and arterial thromboembolism: frequency distribution in a healthy German population. Hoppe B; Tolou F; Dörner T; Kiesewetter H; Salama A Thromb Haemost; 2006 Oct; 96(4):465-70. PubMed ID: 17003923 [TBL] [Abstract][Full Text] [Related]
35. A novel polymorphism in the factor XIII B-subunit (His95Arg): relationship to subunit dissociation and venous thrombosis. Komanasin N; Catto AJ; Futers TS; van Hylckama Vlieg A; Rosendaal FR; Ariëns RA J Thromb Haemost; 2005 Nov; 3(11):2487-96. PubMed ID: 16241947 [TBL] [Abstract][Full Text] [Related]
36. Influence of Amerindian mitochondrial DNA haplogroups on thrombosis susceptibility and frequency of four genetic prothrombotic variants in Southern Chilean subjects. Guzmán N; Lanas F; Salazar LA Clin Chim Acta; 2010 Mar; 411(5-6):444-7. PubMed ID: 20064497 [TBL] [Abstract][Full Text] [Related]
37. Factor XIII Val34Leu polymorphism modulates the prothrombotic and inflammatory state associated with atrial fibrillation. Marín F; Corral J; Roldán V; González-Conejero R; del Rey ML; Sogorb F; Lip GY; Vicente V J Mol Cell Cardiol; 2004 Sep; 37(3):699-704. PubMed ID: 15350843 [TBL] [Abstract][Full Text] [Related]
38. Genetic variation in the fibrinogen gamma gene increases the risk for deep venous thrombosis by reducing plasma fibrinogen gamma' levels. Uitte de Willige S; de Visser MC; Houwing-Duistermaat JJ; Rosendaal FR; Vos HL; Bertina RM Blood; 2005 Dec; 106(13):4176-83. PubMed ID: 16144795 [TBL] [Abstract][Full Text] [Related]
39. Factor XIII polymorphisms and venous thromboembolism. Francis CW Arch Pathol Lab Med; 2002 Nov; 126(11):1391-3. PubMed ID: 12421147 [TBL] [Abstract][Full Text] [Related]
40. Estrogen plus progestin and risk of venous thrombosis. Cushman M; Kuller LH; Prentice R; Rodabough RJ; Psaty BM; Stafford RS; Sidney S; Rosendaal FR; JAMA; 2004 Oct; 292(13):1573-80. PubMed ID: 15467059 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]